1. M11 Nintedanib and pirfenidone for idiopathic pulmonary fibrosis (IPF) in north east england – real life data. (12th November 2019) Authors: Murphy, CJ; Donaldson, C; Langlands, L; Wiscombe, S; Simpson, AJ; Forrest, IA Journal: Thorax Issue: Volume 74(2019)Supplement 2 Page Start: A240 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. M13 From interstitial lung disease (ILD) multidisciplinary team meeting (MDT) to anti-fibrotic medication – review of regional MDT referrals. (12th November 2019) Authors: Murphy, CJ; Donaldson, C; Langlands, L; Wiscombe, S; Simpson, AJ; Forrest, IA Journal: Thorax Issue: Volume 74(2019)Supplement 2 Page Start: A242 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P276 Characterisation Of Reflux And Aspiration In Idiopathic Pulmonary Fibrosis; An Integrated Approach. (10th November 2014) Authors: Jones, RT; Krishnan, A; Zeybel, GL; Pearson, JP; Simpson, AJ; Griffin, SM; Ward, C; Forrest, IA Journal: Thorax Issue: Volume 69(2014)Supplement 2 Page Start: A194 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗